[HTML][HTML] Neutralization of ba. 4–ba. 5, ba. 4.6, ba. 2.75. 2, bq. 1.1, and xbb. 1 with bivalent vaccine
J Zou, C Kurhade, S Patel, N Kitchin… - … England Journal of …, 2023 - Mass Medical Soc
J Zou, C Kurhade, S Patel, N Kitchin, K Tompkins, M Cutler, D Cooper, Q Yang, H Cai…
New England Journal of Medicine, 2023•Mass Medical SocNeutralization of BA.4–BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine |
NEJM Skip to main content NEJM Group Follow Us Facebook Twitter Instagram YouTube
LinkedIn Prepare to become a physician, build your knowledge, lead a health care
organization, and advance your career with NEJM Group information and services. NEJM
Evidence NEW! A digital journal for innovative original research and fresh, bold ideas in
clinical trial design and clinical decision-making. NEJM Catalyst NEW! Peer-reviewed …
NEJM Skip to main content NEJM Group Follow Us Facebook Twitter Instagram YouTube
LinkedIn Prepare to become a physician, build your knowledge, lead a health care
organization, and advance your career with NEJM Group information and services. NEJM
Evidence NEW! A digital journal for innovative original research and fresh, bold ideas in
clinical trial design and clinical decision-making. NEJM Catalyst NEW! Peer-reviewed …
Bivalent Vaccine to Neutralize Omicron Variants
Participants who had received three doses of BNT162b2 vaccine received either a fourth dose or a bivalent vaccine containing BA.4–BA.5 mRNA; the latter group had higher neutralization against omicron variants.
The New England Journal Of Medicine